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Background: Anasarca in patients with lymphoma is a rare symptom. We report a patient with DLBCL associated
with pituitary gland infiltration that was diagnosed based on significant anasarca.
Case presentation: A 72-year-old woman with a 10-year history of hypertension visited a local hospital presenting
with anasarca and 15-kg weight gain in the past 3 months. we clinically diagnosed central hypothyroidism caused
by pituitary gland infiltration of diffuse large B-cell lymphoma (DLBCL) (clinical stage IV in the Ann Arbor staging
classification). The first course of chemotherapy improved anasarca remarkably and the patient’s body weight
returned to what it was 3 months before.
Conclusions: We experienced a patient with remarkable anasarca caused by DLBCL infiltration of the pituitary
gland. A pituitary gland lesion with central hypothyroidism should be considered as one of the differential
diagnoses of edema. This case was very valuable because we could assess it by following the time course of
symptoms (edema and delayed relaxation time of the Achilles tendon reflex), laboratory data, and imaging findings
(swelling anterior pituitary lobe).
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Correct diagnosis is occasionally difficult in some pa-
tients with lymphoma. Typical symptoms of lymphoma,
called B symptoms, include fever, night sweats, and
weight loss. However, atypical manifestations are ob-
served in some patients with lymphoma. Anasarca in pa-
tients with lymphoma is a rare symptom [1].
Diffuse large B-cell lymphoma (DLBCL) reveals extra-
nodal involvements in more than 30% of patients at
diagnosis [2,3]. The gastrointestinal tract, bone marrow,
pancreas, liver, intravascular system, or brain is involved
in patients with DLBCL. Some reports have shown the
pituitary gland with extranodal involvement in patients
with lymphoma [4,5].
We report a patient with DLBCL associated with pitu-
itary gland infiltration that was diagnosed based on sig-
nificant anasarca.* Correspondence: smile.kenzaka@jichi.ac.jp
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A 72-year-old woman with a 10-year history of hyper-
tension visited a local hospital presenting with anasarca
and 15-kg weight gain in the past 3 months. She did not
have fever, appetite loss, night sweats, or dyspnea. Because
of elevated liver enzymes and abdominal computed tom-
ography (CT) abnormalities, including splenomegaly and
multiple splenic tumors, she was referred to our hospital.
On admission, physical examination of the patient re-
vealed the following: temperature, 36.3 °C; pulse rate, 84
beats per minute, regular; blood pressure, 132/74 mmHg;
and respiration rate, 18 breaths per minute. Although
she had remarkable anasarca, she seemed in no distress.
Her height was 143.5 cm, body weight 71 kg, and body
mass index 34.2. She had no jugular venous distention.
Lymphadenopathy was not noted. No crackles were aud-
ible, but there were diminished breath sounds in the
base of the right lung. She had remarkable nonpitting
and slow pitting mixed edema of the legs. A delayed re-
laxation time of the Achilles tendon reflex was observed.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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blood cell count, 7,400 cells/mm3; hemoglobin, 11.6 g/dL;
platelet count, 103,000/μL; total protein, 6.0 g/dL; albumin,
2.9 g/dL; aspartate aminotransferase, 27 IU/L; alanine ami-
notransferase, 20 IU/L; lactate dehydrogenase, 707 IU/L;
alkaline phosphatase, 629 IU/L; total-bilirubin, 0.69 mg/dL;
blood urea nitrogen, 11 mg/dL; creatinine, 0.65 mg/dL;
creatinine kinase, 15 IU/L; thyroid-stimulating hormone
(TSH), 0.45 μU/mL (standard value: 0.45-3.33 μU/mL);
free thyroxine (FT4), 0.37 ng/dL (standard value: 0.84-
1.44 ng/dL); free triiodothyronine (FT3), 0.89 pg/mL
(standard value: 2.11-3.51 pg/mL); and soluble interleukin-
2 receptor, 6,660 U/mL (standard value: 124–466 U/mL).
Urinary protein level was 0.2 g/g creatinine. A contrast-
enhanced CT of the head, neck, chest, abdomen, and
pelvis revealed splenomegaly and multiple spleen tumors
(Figure 1), whereas there was no lymphadenopathy. CT-
guided biopsy of the spleen was performed, which showed
aggregated large atypical cells. The individual cells had the
chromatin-rich nuclei and relatively abundant intracyto-
plasmic eosinophilic inclusion bodies (Figure 2). Immuno-
histochemistry showed that the atypical cells were positive
for CD20 and CD79a, and negative for CD3 and CD10.
Histopathology and immunohistochemistry of the spleen
led to the diagnosis of DLBCL.
We assessed the central hypothyroidism because of
anasarca, delayed Achilles tendon reflex, and low FT4.
Head magnetic resonance imaging (MRI) revealed
swelling of pituitary gland, but a normal-size of pituitary
gland was confirmed in a head MRI performed 1 year
before (Figure 3a, b). Luteinizing hormone (LH) and
follicle-stimulating hormone (FSH) were also at low
levels (LH 0.3 mIU/mL [standard value: 6.7-38.0 mIU/
mL] and FSH 3.4 mIU/mL [standard value: 26.2-113.3
mIU/mL]). Cortisol level was 21.6 μg/dL [standard value:
4.0-18.3μg/dL] and ACTH was 33.4 pg/mL [standard
value: 7.2-63.3 pg/mL]. Prolactin was 9.2 ng/mL[stand-
ard value: 3.12-15.39 ng/mL(menopause women) ]. AVP
level was not measured but there were no polyuria and
hyponatremia. We diagnosed pituitary anterior lobe hor-
mone insufficiency.Figure 1 Contrast-enhanced abdominal computed tomography imag
phase. Splenomegaly and multiple spleen tumors were observed. The max
(white arrows).Positron emission tomography (PET) scan revealed a
localized accumulation in the pituitary gland, spleen,
and para-abdominal aorta lymph nodes (Figure 4). Pitu-
itary gland biopsy was not performed; however, we clin-
ically diagnosed central hypothyroidism caused by
pituitary gland infiltration of DLBCL (clinical stage IV in
the Ann Arbor staging classification).
She received 25 μg per day of levothyroxine for one
week before the chemotherapy. However, the dose and
duration of levothyroxine were not enough. The first
course of chemotherapy for DLBCL including methotrex-
ate, vincristine, ifosfamide, and dexamethasone, which im-
proved anasarca remarkably and the patient’s body weight
returned to what it was 3 months before. Moreover, thy-
roid hormone, LH, and FSH levels normalized and the pi-
tuitary gland swelling improved (Figure 3c), although
thyroid hormone replacement therapy was not effective
before chemotherapy (Figure 5). We chose a second
course of chemotherapy that comprised cyclophospha-
mide, hydroxydaunorubicin, vincristine, and prednisone
(CHOP) because there were no atypical cells in the pa-
tient’s cerebrospinal fluid. This second course of chemo-
therapy led to remission and the same chemotherapy
regimen was repeated.
Discussion
Here, we describe a case of pituitary gland infiltration of
DLBCL associated with central hypothyroidism, which
caused remarkable anasarca. In this case, only a few clinical
manifestation were anasarca and a delayed relaxation time
of the Achilles tendon reflex, other than the typical symp-
toms of lymphoma (fever, night sweats, and weight loss).
Pituitary gland involvement as extranodal lymphoma is
comparatively rare [4,5], and DLBCL is one of the most
frequent histological types for pituitary gland involvement
[2]. Infiltration of lymphoma cells to the pituitary gland
lead to headache, opthalmoplegia, or hemianopia [6], and
often causes diabetes insipidus [6]. Anasarca is a rare
symptom in patients with lymphoma [1].
Moreover, lymphoma with pituitary gland infiltration
seldom shows significant anasarca or weight gain causede of the abdomen. (a) Plain phase. (b) Arterial phase. (c) Equilibrium
imal tumor size was 52 mm and the tumor had a necrotic lesion
Figure 2 Histopathology finding of the spleen. (a) Hematoxylin-eosin stain. Aggregated large atypical cells were seen. The individual cells had
chromatin-rich nuclei and relatively abundant intracytoplasmic eosinophilic inclusion bodies. (b) CD20 stain. Atypical cells were positive for CD20.
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with lymphoma who have pituitary gland involvement
have no symptom, and they are incidentally detected
using PET or MRI [7]. We clinically diagnosed infiltra-
tion of a malignant lymphoma in the pituitary gland
based on time-dependent changes in MRI findings, thy-
roid hormone, LH, and FSH levels before and after
chemotherapy; and PET findings.
Infiltration of DLBCL cells to the pituitary gland caused
secondary central hypothyroidism, and secondary central
hypothyroidism led to anasarca and weight gain in our pa-
tient. Nonpitting edema was noted, provably caused by
hypothyroidism, and slow pitting edema resulting from
hypoalbuminemia was observed simultaneously.
Elderly people often have several disorders at the
same time; however, we believe that, in explaining man-
ifestations, one disorder should account for everyFigure 3 Head magnetic resonance imaging. White arrows indicate the
(b) Time of diagnosis. Pituitary gland swelling but keeping signal of poster
gland swelling improved.symptom. In this case, the patient had remarkable ana-
sarca because of DLBCL involvement of the pituitary
gland. This case was very valuable because we could as-
sess the patient’s abnormalities; that is to say, anasarca,
weight gain, hypothyroidism, elevated lactate dehydro-
genase and alkaline phosphatase, splenomegaly, and
swelling of the pituitary gland caused by malignant
lymphoma and its infiltration into the pituitary gland.
In this era of longevity, the prevalence of diseases
increases, and we must anticipate the greater likeli-
hood of multiple, simultaneous diagnoses [8]. Hickam’s
dictum and Occam’s razor are well suited to this case.
“A patient can have as many diagnoses as he darn
well pleases” [8]. This is Hickam’s dictum. However,
William of Ockham stated “Among competing hypoth-
eses, favor the simplest one” [8]. This is known as
Occam’s razor.pituitary gland. (a) One year before. Normal-sized pituitary gland.
ior lobe of pituitary. (c) After one course of chemotherapy. Pituitary
Figure 4 Positron emission tomography (PET) scan. PET scan revealed a localized accumulation in the pituitary gland (a), spleen (b), and
para-abdominal aorta lymph nodes (c) (red circles).
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megaly, and multiple spleen tumors that resulted from
the malignant lymphoma. It was also easy to assess ana-
sarca that was due to hypothyroidism and hypoalbumin-
emia. In this case, however, we reached the correct
diagnosis of pituitary gland involvement from DLBCL,
which manifested significant anasarca, according to
Occam’s razor. A pituitary gland lesion with centralFigure 5 Clinical course. First course chemotherapy including methotrexa
body weight was reverted as same as 3 months before. Moreover, thyroid
chemotherapy as cyclophosphamide, hydroxydaunorubicin, vincristine, and
chemotherapy was repeated.hypothyroidism should be considered as one of the
differential diagnoses of edema, especially nonpitting
edema in some cases.
Conclusion
We experienced a patient with remarkable anasarca
caused by DLBCL infiltration of the pituitary gland. A pi-
tuitary gland lesion with central hypothyroidism should bete, vincristine, ifosfamide, and dexamethasone improved anasarca and
hormone, LH, and FSH became normal levels. Second course
prednisone (CHOP) led to remission and the same regimen of
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This case was very valuable because we could assess it by
following the time course of symptoms, laboratory data,
and imaging findings.
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